Evidence map›Paper›PMID 37954104›Full record

ArticleOpen life sciences2023

A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis.

Abdulla Mousa Falah Alali, Dhyaram Lakshmi Padmaja, Mukesh Soni, Muhammad Attique Khan, Faheem Khan, Isaac Ofori

RetractedAbstract readRetracted Publication
In one paragraph

Article in Open life sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Abdulla Mousa Falah AlaliDepartment of Computer Science, Isra University, Amman, Jordan.
Dhyaram Lakshmi PadmajaDepartment of Information Technology, Anurag University, Hyderabad, Telangana, India.
Mukesh SoniDepartment of CSE, University Centre for Research & Development, Chandigarh University, Mohali, Punjab 140413, India.
Muhammad Attique KhanDepartment of Computer Science and Mathematics, Lebanese American University, Beirut, Lebanon.
Faheem KhanDepartment of Computer Engineering, Gachon University, Seongnam-si, South Korea.
Isaac OforiDepartment of Environmental and Safety Engineering, University of Mines and Technology (UMaT), Tarkwa, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is a substantial health issue globally, and it is one of the main causes of mortality. Malignant mesothelioma (MM) is a common kind of lung cancer. The majority of patients with MM have no symptoms. In the diagnosis of any disease, etiology is crucial. MM risk factor detection procedures include positron emission tomography, magnetic resonance imaging, biopsies, X-rays, and blood tests, which are all necessary but costly and intrusive. Researchers primarily concentrated on the investigation of MM risk variables in the study. Mesothelioma symptoms were detected with the help of data from mesothelioma patients. The dataset, however, included both healthy and mesothelioma patients. Classification algorithms for MM illness diagnosis were carried out using computationally efficient data mining techniques. The support vector machine outperformed the multilayer perceptron ensembles (MLPE) neural network (NN) technique, yielding promising findings. With 99.87% classification accuracy achieved using 10-fold cross-validation over 5 runs, SVM is the best classification when contrasted to the MLPE NN, which achieves 99.56% classification accuracy. In addition, SPSS analysis is carried out for this study to collect pertinent and experimental data.

Indexed as

lung cancermagnetic resonance imagingmalignant mesotheliomassupport vector machine

Identifiers

PMID37954104
PMCPMC10638843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.